• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • Our Services
  • Contact Us
  • Newsletter
  • Top Nav Social Icons

Mobile ID World

Mobile ID World

Identification Revolution

  • Mobile ID
    • What Is Mobile ID?
    • Identity Associations
    • Premier Partners
    • FAQ
  • News
  • Solutions
    • Behavioral
    • Facial Recognition
    • Fingerprint Biometrics
    • Iris Biometrics
    • Second Factor
    • Smart Cards
    • Smartphones
    • Vital
    • Voice
    • Wearable Tech
    • Other
  • Applications
    • Access Control
    • Cloud Technology
    • Commerce
    • Enterprise
    • Healthcare
    • Identification
    • Internet of Things
    • Law Enforcement
    • Strong Online Authentication
  • Exclusive
    • Interviews
    • Featured Articles
    • Podcasts
  • Companies
  • Events

FDA Certifies Medical-Grade ScanWatch Device

October 14, 2021

Withings’ ScanWatch now has the formal approval of the US Food and Drug Administration (FDA). The certification covers the ScanWatch’s electrocardiogram (ECG) and blood oxygen detection (SpO2) capabilities, and clears the watch for use in medical applications.

FDA Certifies Medical-Grade ScanWatch Device

In that regard, the ScanWatch is expected to serve as a diagnostic tool. The ECG is a heart rate monitor that can detect cardiac conditions like atrial fibrillation (AFib), while the SpO2 sensor can help track respiratory problems like sleep apnea and COVID-19. In those cases, lower blood oxygen levels serve as an indicator of a more serious breathing issue.

The ScanWatch has already been used in two clinical trials, including a German study in which doctors used it to monitor patients’ COVID-19 symptoms remotely. The watch also has fitness and sleep trackers that go beyond its utility as a medical device. For example, the watch can track steps, calories, and different kinds of workout routines, and comes with a VO2 Max indicator that gauges how well the wearer converts oxygen into physical output while exercising. The result serves as an estimate of someone’s overall fitness level.

All of the data gathered with the ScanWatch can be viewed in the free Health Mate companion app. Wearers can then choose to send that data to their doctor should they wish to do so. The watch itself is water-resistant to a depth of five meters.

The ScanWatch originally debuted at CES 2020, where it received three CES Innovation Awards. The watch is already available in Europe and Australia, but the FDA certification clears the way for a launch in the United States. Withings has indicated that the device will enter the US market in November.

“We are now thrilled to bring it to the United States following robust FDA scrutiny,” said Withings CEO Mathieu Letombe. “Our mission is to create devices people use and wear every day so the medical data they provide can make meaningful impacts on their lives. ScanWatch is our most ambitious medical watch to date and has the potential to benefit millions of people.”

The Withings ScanWatch will retail for $279, though there is a 42 mm version available for $300. Heart rate and blood oxygen detection have become increasingly common in the latest generation of smartwatches, though the ScanWatch is the first wearable with both ECG and SpO2 certification from the FDA.

Source: VentureBeat

Filed Under: Industry News Tagged With: biometric wearables, ECG biometrics, FDA approval, fitness tracking biometrics, fitness tracking wearables, healthcare biometrics, heart rate tracking, spO2, spO2 tracking, wearables, Withings, Withings ScanWatch

Related News & Articles

Thai MNO DTAC Embraces IDEMIA eSIM Provisioning for Smartwatch

Taiwan’s BCC Building Biometric Card On Zwipe Platform

Police in China Expand Use of Biometric Wearables

Primary Sidebar

Learn About Mobile ID and Aviation

Tweets

Sponsored Links

facetec logo

FaceTec’s patented, industry-leading 3D Face Authentication software anchors digital identity, creating a chain of trust from user onboarding to ongoing authentication on all modern smart devices and webcams. FaceTec’s 3D FaceMaps™ make trusted, remote identity verification finally possible. As the only technology backed by a persistent spoof bounty program and NIST/iBeta Certified Liveness Detection, FaceTec is the global standard for Liveness and 3D Face Matching with millions of users on six continents in financial services, border security, transportation, blockchain, e-voting, social networks, online dating and more. www.facetec.com

FACEPHI is a global leader in Facial Recognition technology and in Mobile Biometrics technologies. With a strong concentration in the financial sector, FacePhi’s product is rapidly becoming a service used by banks all over the world. Its implementation doesn’t just save money, it is also a way to attract clients and build loyalty, while increasing the security of transactions for both the customer and the business. To learn more about FacePhi, visit https://www.facephi.com/en/

Recent Posts

  • NordPass, Yahoo! Japan, and Regula Keep Up Mobile Biometrics Momentum
  • NordPass Enables Biometric, TOTP-secured 2FA for Business Users
  • Mastercard Solution Certified Under UK’s Digital ID Framework
  • Transatlantic Digital Traveler Identity Project Gets High-Profile Tech Partner
  • Digital Identity Tech Demo Online Event

Footer

  • About Us
  • Company Directory
  • Advertise With Us
  • Contact Us
  • Privacy Policy
  • Terms of Use
  • Archives
  • CCPA: Do not sell my personal info.

Follow Us

Copyright © 2023 MobileIDWorld